|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
5R01CA176179-04
|
$347,563
|
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Yap and beta-catenin interactions in liver: Implications in Pathophysiology
|
5R01CA204586-02
|
$414,072
|
|
MONGA, SATDARSHAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Work Ability in Young Adult Surviviors (WAYS): A Quantitative Investigation
|
5R21CA191989-02
|
$168,563
|
|
DANHAUER, SUZANNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-05
|
$2,260,718
|
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Weight cycling and total and site-specific cancer incidence and mortality
|
1R03CA204825-01A1
|
$79,354
|
|
GIOVANNUCCI, EDWARD
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Web-based Smoking Cessation Program for Tribal College Students
|
5R01CA174481-05
|
$556,175
|
|
CHOI, WON
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Visual Media Influences on Adolescent Smoking Behavior
|
5R01CA077026-18
|
$521,341
|
|
SARGENT, JAMES
|
DARTMOUTH COLLEGE
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-02
|
$1,537,769
|
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)
|
5R01CA154823-06
|
$646,350
|
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients
|
5R01CA193706-02
|
$556,045
|
|
WYATT, GWEN
|
MICHIGAN STATE UNIVERSITY
|
|
Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
|
5R01CA188523-04
|
$323,700
|
|
WALLER, EDMUND
|
EMORY UNIVERSITY
|
|
Use of Alternative Tobacco Products Among Homeless Youth
|
1R01CA204004-01A1
|
$404,103
|
|
TUCKER, JOAN
|
RAND CORPORATION
|
|
University of Maryland, Baltimore Biomarker Reference Laboratory
|
5U24CA115091-12
|
$456,438
|
|
STASS, SANFORD
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Understanding resistance in the HER2-HER3 tumor drive
|
5R01CA122216-10
|
$298,554
|
|
MOASSER, MARK
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders
|
5R01CA194263-02
|
$632,188
|
|
FANG, CAROLYN
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Understanding optimal delivery systems for cancer care
|
5R01CA174768-04
|
$377,699
|
|
MILLER, DAVID
|
UNIVERSITY OF MICHIGAN
|
|
Understanding how graphic warnings on cigarette packs increase quit intentions
|
5F31CA196037-02
|
$4,928
|
|
HALL, MARISSA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Understanding Breast Cancer Metastasis to Lymph Node
|
5R21CA199621-02
|
$168,563
|
|
MOHAMMED, SULMA
|
PURDUE UNIVERSITY
|
|
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism
|
1R01CA204969-01A1
|
$332,357
|
|
NAGRATH, DEEPAK
|
UNIVERSITY OF MICHIGAN
|
|
Ultrasound imaging and enhanced therapeutic response
|
5R01CA134659-09
|
$499,000
|
|
FERRARA, KATHERINE
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Tumor-targeted Polymersomes to image and Treat Ovarian Cancer
|
5R01CA175480-05
|
$327,536
|
|
CHENG, ZHILIANG
|
UNIVERSITY OF PENNSYLVANIA
|
|
Tumor vasculature-targeted nanotherapeutics for DNA damage response
|
5R01CA193880-02
|
$364,856
|
|
SHEN, HAIFA
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
|
5P01CA067166-20
|
$1,585,768
|
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
|
Tumor Heterogeneity and Acquired Resistance to EGFR Inhibition
|
5R01CA184843-03
|
$623,897
|
|
KOPETZ, SCOTT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Tryptophan metabolism in human brain tumors
|
5R01CA123451-09
|
$327,341
|
|
JUHASZ, CSABA
|
WAYNE STATE UNIVERSITY
|
|
Treatment and Outcomes in Diabetic Breast Cancer Patients
|
5R01CA188353-03
|
$406,860
|
|
GOLD, HEATHER
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Translating Novel Drug-Targetable Biomarkers to Treat Graft versus Host Disease
|
5R01CA168814-05
|
$69,085
|
|
PACZESNY, SOPHIE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition
|
5R01CA183071-04
|
$657,802
|
|
VIGNERON, DANIEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Transcription-dependent and -independent signaling of RSK2 in cancer metastasis
|
5R01CA175316-04
|
$323,700
|
|
KANG, SUMIN
|
EMORY UNIVERSITY
|
|
Training in Translational Research of Lung, Head and Neck Cancer
|
5T32CA174648-05
|
$425,474
|
|
WANG, XIAO-JING
|
UNIVERSITY OF COLORADO DENVER
|
|
Towards Understanding Prostate Cancer Heterogeneity
|
5R01CA125612-09
|
$372,410
|
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Toward a screening designation for SoftVue: A multi-center clinical trial in support of Pre-Market Approval.
|
5R44CA165320-05
|
$962,653
|
|
DURIC, NEBOJSA
|
DELPHINUS MEDICAL TECHNOLOGIES, INC.
|
|
Tobacco Use during the Transition to Adulthood
|
5R01CA141643-07
|
$534,246
|
|
SUTFIN, ERIN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Tobacco Companies, Public Policy and Global Health
|
5R01CA091021-14
|
$515,442
|
|
LEE, KELLEY
|
SIMON FRASER UNIVERSITY
|
|
Time to first cigarette and early detection in the National Lung Screening Trial
|
5R03CA201951-02
|
$77,350
|
|
MUSCAT, JOSHUA
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
|
ZIA BC 010801
|
$719,531
|
$719,531
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
|
5R01CA166280-05
|
$318,513
|
|
CALVI, LAURA
|
UNIVERSITY OF ROCHESTER
|
|
Theranostic nanoparticles for the treatment of RAI refractory thyroid cancer
|
5R01CA178007-05
|
$351,713
|
|
JIN, MOONSOO
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
The Yap-Tead transcriptional complex in Kras-induced Pancreatic Ductal Adenocarci
|
5R01CA187090-04
|
$322,663
|
|
YI, CHUNLING
|
GEORGETOWN UNIVERSITY
|
|
The role of wild-type KRAS in the context of tumor profession and metastasis
|
5R01CA178445-03
|
$462,118
|
|
SU, GLORIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of the Microenvironment in Barrett's Esophagus
|
2U54CA163004-06
|
$1,310,083
|
|
WANG, TIMOTHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of senescent cells in late-life tumorigenesis
|
5R01CA166347-05
|
$343,817
|
|
VAN DEURSEN, JAN
|
MAYO CLINIC ROCHESTER
|
|
The Role of PTP4A3 in Colorectal Tumor Formation and Progression
|
5F31CA196062-02
|
$31,279
|
|
MCQUEENEY, KELLEY
|
UNIVERSITY OF VIRGINIA
|
|
The role of PTEN and AKT2 in the malignant transformation of liver progenitor cel
|
5R01CA154986-05
|
$342,375
|
|
STILES, BANGYAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
The Role of post-translational activation of Myc in pancreatic cancer
|
5R01CA196228-03
|
$390,191
|
|
SEARS, ROSALIE
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The Role of Nup88 Overexpression in Cellular Transformation and Tumorigenesis
|
5F30CA189339-04
|
$42,744
|
|
NAYLOR, RYAN
|
MAYO CLINIC ROCHESTER
|
|
The role of neuroendocrine transdifferentiation of pancreatic cancer cells on tumor progression and chemoresistance.
|
1F32CA213764-01
|
$56,694
|
|
MORRISON JOLY, MEGHAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The role of mutant p53 and endocytic recycling in ESCC invasion and metastasis
|
5F32CA206264-02
|
$57,066
|
|
LENTO, ASHLEY
|
UNIVERSITY OF PENNSYLVANIA
|
|
The role of MDM2-MTBP axis in cancer metastasis
|
5R01CA174735-04
|
$313,325
|
|
IWAKUMA, TOMOO
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
5R01CA166749-06
|
$315,213
|
|
ZAGE, PETER
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
Total relevant funding to Neurofibromatosis for this search: $8,682,029
|